Elicio Therapeutics, Inc (ELTX) insider trading
Every open-market stock purchase and sale by Elicio Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Yekaterina Chudnovsky (Insider), $20M, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $1.94 on Oct 22, 2026.
Recent ELTX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 31, 2026 | Allen Nissenson (Director) | Bought (not open market) | — |
| Aug 31, 2026 | Jay Venkatesan (Director) | Bought (not open market) | — |
| Aug 31, 2026 | Robert R Ruffolo (Director) | Bought (not open market) | — |
| Aug 31, 2026 | Yekaterina Chudnovsky (10% owner) | Bought (not open market) | — |
| Aug 31, 2026 | Carol Gail Ashe (Director) | Bought (not open market) | — |
| Aug 31, 2026 | Karen J Wilson (Director) | Bought (not open market) | — |
| Aug 31, 2026 | Julian Adams (Director) | Bought (not open market) | — |
| Jul 16, 2026 | Peter DeMuth (C-suite exec) | Bought (not open market) | — |
| Jul 16, 2026 | Preetam Shah (Officer) | Bought (not open market) | — |
| Jul 16, 2026 | Christopher Haqq (Officer) | Bought (not open market) | — |
| Jul 16, 2026 | Robert Connelly (CEO) | Bought (not open market) | — |
| Feb 2, 2026 | Peter DeMuth (C-suite exec) | Bought (not open market) | — |
| Feb 2, 2026 | Peter DeMuth (C-suite exec) | Bought (not open market) | — |
| Feb 2, 2026 | Christopher Haqq (Officer) | Bought (not open market) | — |
| Feb 2, 2026 | Christopher Haqq (Officer) | Bought (not open market) | — |
| Feb 2, 2026 | Preetam Shah (Officer) | Bought (not open market) | — |
| Feb 2, 2026 | Robert Connelly (CEO) | Bought (not open market) | — |
| Feb 2, 2026 | Robert Connelly (CEO) | Bought (not open market) | — |
| Feb 2, 2026 | Preetam Shah (Officer) | Bought (not open market) | — |
| Dec 9, 2025 | Peter DeMuth (C-suite exec) | Bought (not open market) | — |
Who's trading ELTX
- Karen J Wilson, Director: other filings, last Aug 31, 2026
- Carol Gail Ashe, Director: other filings, last Aug 31, 2026
- Yekaterina Chudnovsky, Insider: other filings, last Aug 31, 2026
- Allen Nissenson, Director: other filings, last Aug 31, 2026
- Robert R Ruffolo, Director: other filings, last Aug 31, 2026
- Jay Venkatesan, Director: other filings, last Aug 31, 2026
- Julian Adams, Director: other filings, last Aug 31, 2026
- Robert Connelly, CEO: other filings, last Jul 16, 2026
- Peter DeMuth, C-suite exec: other filings, last Jul 16, 2026
- Christopher Haqq, Officer: other filings, last Jul 16, 2026
- Preetam Shah, Officer: other filings, last Jul 16, 2026
Get free alerts when an insider at Elicio Therapeutics, Inc files a new trade →